Glumetinib Clinical Trials

2 actively recruiting trials across 1 location

Also known as: SCC244

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

Shanghai JMT-Bio Inc.1
Haihe Biopharma Co., Ltd.1

Indications

Lung Cancer2
Cancer2
C-Met Exon 14 Mutation1
Non Small Cell Lung Cancer1

Other1 trial

A Study to Evaluate the Efficacy and Safety of Glumetinib Combined With Osimertinib Mesylate Versus Platinum-based Doublet Chemotherapy in Non-Small Cell Lung Cancer Patients After Resistance to EGFR-TKIs

Phase 3

Louisville, Kentucky1 trial

Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer

Norton Cancer Institute

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.